These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 39080379)

  • 1. TRPML1 activation ameliorates lysosomal phenotypes in CLN3 deficient retinal pigment epithelial cells.
    Wünkhaus D; Tang R; Nyame K; Laqtom NN; Schweizer M; Scotto Rosato A; Krogsæter EK; Wollnik C; Abu-Remaileh M; Grimm C; Hermey G; Kuhn R; Gruber-Schoffnegger D; Markmann S
    Sci Rep; 2024 Jul; 14(1):17469. PubMed ID: 39080379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cln3-mutations underlying juvenile neuronal ceroid lipofuscinosis cause significantly reduced levels of Palmitoyl-protein thioesterases-1 (Ppt1)-protein and Ppt1-enzyme activity in the lysosome.
    Appu AP; Bagh MB; Sadhukhan T; Mondal A; Casey S; Mukherjee AB
    J Inherit Metab Dis; 2019 Sep; 42(5):944-954. PubMed ID: 31025705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of CLN3, the gene mutated in juvenile neuronal ceroid lipofuscinosis, leads to metabolic impairment and autophagy induction in retinal pigment epithelium.
    Zhong Y; Mohan K; Liu J; Al-Attar A; Lin P; Flight RM; Sun Q; Warmoes MO; Deshpande RR; Liu H; Jung KS; Mitov MI; Lin N; Butterfield DA; Lu S; Liu J; Moseley HNB; Fan TWM; Kleinman ME; Wang QJ
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165883. PubMed ID: 32592935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CLN3 is required for the clearance of glycerophosphodiesters from lysosomes.
    Laqtom NN; Dong W; Medoh UN; Cangelosi AL; Dharamdasani V; Chan SH; Kunchok T; Lewis CA; Heinze I; Tang R; Grimm C; Dang Do AN; Porter FD; Ori A; Sabatini DM; Abu-Remaileh M
    Nature; 2022 Sep; 609(7929):1005-1011. PubMed ID: 36131016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial correction of the CNS lysosomal storage defect in a mouse model of juvenile neuronal ceroid lipofuscinosis by neonatal CNS administration of an adeno-associated virus serotype rh.10 vector expressing the human CLN3 gene.
    Sondhi D; Scott EC; Chen A; Hackett NR; Wong AM; Kubiak A; Nelvagal HR; Pearse Y; Cotman SL; Cooper JD; Crystal RG
    Hum Gene Ther; 2014 Mar; 25(3):223-39. PubMed ID: 24372003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycerophosphodiesters inhibit lysosomal phospholipid catabolism in Batten disease.
    Nyame K; Hims A; Aburous A; Laqtom NN; Dong W; Medoh UN; Heiby JC; Xiong J; Ori A; Abu-Remaileh M
    Mol Cell; 2024 Apr; 84(7):1354-1364.e9. PubMed ID: 38447580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A function retained by the common mutant CLN3 protein is responsible for the late onset of juvenile neuronal ceroid lipofuscinosis.
    Kitzmüller C; Haines RL; Codlin S; Cutler DF; Mole SE
    Hum Mol Genet; 2008 Jan; 17(2):303-12. PubMed ID: 17947292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Converging roles of PSENEN/PEN2 and CLN3 in the autophagy-lysosome system.
    Klein M; Kaleem A; Oetjen S; Wünkhaus D; Binkle L; Schilling S; Gjorgjieva M; Scholz R; Gruber-Schoffnegger D; Storch S; Kins S; Drewes G; Hoffmeister-Ullerich S; Kuhl D; Hermey G
    Autophagy; 2022 Sep; 18(9):2068-2085. PubMed ID: 34964690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the Lysosomal Membrane Protein, CLN3, in the Regulation of Cathepsin D Activity.
    Cárcel-Trullols J; Kovács AD; Pearce DA
    J Cell Biochem; 2017 Nov; 118(11):3883-3890. PubMed ID: 28390177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel role of the Batten disease gene CLN3: association with BMP synthesis.
    Hobert JA; Dawson G
    Biochem Biophys Res Commun; 2007 Jun; 358(1):111-6. PubMed ID: 17482562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photoreceptor phagosome processing defects and disturbed autophagy in retinal pigment epithelium of Cln3Δex1-6 mice modelling juvenile neuronal ceroid lipofuscinosis (Batten disease).
    Wavre-Shapton ST; Calvi AA; Turmaine M; Seabra MC; Cutler DF; Futter CE; Mitchison HM
    Hum Mol Genet; 2015 Dec; 24(24):7060-74. PubMed ID: 26450516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-Complementary AAV9 Gene Delivery Partially Corrects Pathology Associated with Juvenile Neuronal Ceroid Lipofuscinosis (CLN3).
    Bosch ME; Aldrich A; Fallet R; Odvody J; Burkovetskaya M; Schuberth K; Fitzgerald JA; Foust KD; Kielian T
    J Neurosci; 2016 Sep; 36(37):9669-82. PubMed ID: 27629717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unbiased Cell-based Screening in a Neuronal Cell Model of Batten Disease Highlights an Interaction between Ca2+ Homeostasis, Autophagy, and CLN3 Protein Function.
    Chandrachud U; Walker MW; Simas AM; Heetveld S; Petcherski A; Klein M; Oh H; Wolf P; Zhao WN; Norton S; Haggarty SJ; Lloyd-Evans E; Cotman SL
    J Biol Chem; 2015 Jun; 290(23):14361-80. PubMed ID: 25878248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcript and in silico analysis of CLN3 in juvenile neuronal ceroid lipofuscinosis and associated mouse models.
    Chan CH; Mitchison HM; Pearce DA
    Hum Mol Genet; 2008 Nov; 17(21):3332-9. PubMed ID: 18678598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective lysosomal arginine transport in juvenile Batten disease.
    Ramirez-Montealegre D; Pearce DA
    Hum Mol Genet; 2005 Dec; 14(23):3759-73. PubMed ID: 16251196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulating membrane fluidity corrects Batten disease phenotypes in vitro and in vivo.
    Schultz ML; Tecedor L; Lysenko E; Ramachandran S; Stein CS; Davidson BL
    Neurobiol Dis; 2018 Jul; 115():182-193. PubMed ID: 29660499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulation with minocycline rescues retinal degeneration in juvenile neuronal ceroid lipofuscinosis mice highly susceptible to light damage.
    Dannhausen K; Möhle C; Langmann T
    Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30042155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A human model of Batten disease shows role of CLN3 in phagocytosis at the photoreceptor-RPE interface.
    Tang C; Han J; Dalvi S; Manian K; Winschel L; Volland S; Soto CA; Galloway CA; Spencer W; Roll M; Milliner C; Bonilha VL; Johnson TB; Latchney L; Weimer JM; Augustine EF; Mink JW; Gullapalli VK; Chung M; Williams DS; Singh R
    Commun Biol; 2021 Feb; 4(1):161. PubMed ID: 33547385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Juvenile CLN3 disease is a lysosomal cholesterol storage disorder: similarities with Niemann-Pick type C disease.
    Chen J; Soni RK; Xu Y; Simoes S; Liang FX; DeFreitas L; Hwang R; Montesinos J; Lee JH; Area-Gomez E; Nandakumar R; Vardarajan B; Marquer C
    EBioMedicine; 2023 Jun; 92():104628. PubMed ID: 37245481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRPML1-/TFEB-Dependent Regulation of Lysosomal Exocytosis.
    Di Paola S; Medina DL
    Methods Mol Biol; 2019; 1925():143-144. PubMed ID: 30674023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.